Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akhtar Ashfaq

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Current Medical Research and Opinion|November 20, 2015
Time savings of weekly versus three-times-per-week administration of erythropoiesis stimulating agents in United States dialysis patientsJ Mark Stephens, Larry C Emerson, Leslie A Spry, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|August 24, 2013
TSAT is a better predictor than ferritin of hemoglobin response to Epoetin alfa in US dialysis patientsAdam E Gaweda, Premila Bhat, Gregory A Maglinte, et al.
American Journal of Nephrology|February 23, 2025
Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized TrialAkhtar Ashfaq, John Choe, Stephen A Strugnell, et al.
BMC Nephrology|November 11, 2022
Real-world assessment: effectiveness and safety of extended-release calcifediol and other vitamin D therapies for secondary hyperparathyroidism in CKD patientsMichael J Germain, Subir K Paul, George Fadda, et al.
BMC Nephrology|November 6, 2012
Outpatient red blood cell transfusion payments among patients on chronic dialysisMatthew Gitlin, J Andrew Lee, David M Spiegel, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|December 18, 2022
REsCue trial: Randomized controlled clinical trial with extended-release calcifediol in symptomatic COVID-19 outpatientsCharles W Bishop, Akhtar Ashfaq, Joel Z Melnick, et al.
Journal of the American Society of Nephrology : JASN|January 26, 2019
Excess Deaths Attributable to Influenza-Like Illness in the ESRD PopulationDavid T Gilbertson, Kenneth J Rothman, Glenn M Chertow, et al.
Journal of the American Society of Nephrology : JASN|February 27, 2016
Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment ReformGlenn M Chertow, Jiannong Liu, Keri L Monda, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Current Medical Research and Opinion|November 20, 2015
Time savings of weekly versus three-times-per-week administration of erythropoiesis stimulating agents in United States dialysis patientsJ Mark Stephens, Larry C Emerson, Leslie A Spry, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|August 24, 2013
TSAT is a better predictor than ferritin of hemoglobin response to Epoetin alfa in US dialysis patientsAdam E Gaweda, Premila Bhat, Gregory A Maglinte, et al.
American Journal of Nephrology|February 23, 2025
Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized TrialAkhtar Ashfaq, John Choe, Stephen A Strugnell, et al.
BMC Nephrology|November 11, 2022
Real-world assessment: effectiveness and safety of extended-release calcifediol and other vitamin D therapies for secondary hyperparathyroidism in CKD patientsMichael J Germain, Subir K Paul, George Fadda, et al.
BMC Nephrology|November 6, 2012
Outpatient red blood cell transfusion payments among patients on chronic dialysisMatthew Gitlin, J Andrew Lee, David M Spiegel, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|December 18, 2022
REsCue trial: Randomized controlled clinical trial with extended-release calcifediol in symptomatic COVID-19 outpatientsCharles W Bishop, Akhtar Ashfaq, Joel Z Melnick, et al.
Journal of the American Society of Nephrology : JASN|January 26, 2019
Excess Deaths Attributable to Influenza-Like Illness in the ESRD PopulationDavid T Gilbertson, Kenneth J Rothman, Glenn M Chertow, et al.
Journal of the American Society of Nephrology : JASN|February 27, 2016
Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment ReformGlenn M Chertow, Jiannong Liu, Keri L Monda, et al.
Pageof 3